TBI and spinal cord injury carry chronic multisystem risk long after the acute event
Traumatic brain injury and spinal cord injury are being recast as far more than isolated emergencies. In a commentary in The Lancet Neurology, Marini and colleagues argue that traumatic brain injury and spinal cord injury in adults should be recognized as acute-onset multisystem chronic-risk conditions, not as injuries that end when the initial hospitalization ends.
The framing is blunt because the consequences are blunt. More than 220 million people worldwide live with the downstream effects of these injuries, and those effects extend across cardiometabolic, endocrine, neurological, and psychiatric domains for years to decades after the original trauma. A care model built around the acute injury alone leaves the biology of recovery and decline unattended.
Why the current model misses the biology of neurotrauma
The central problem is structural. Health systems still tend to treat neurotrauma as a time-limited event, with follow-up that is fragmented, inconsistent, or absent once the acute phase has passed. For many patients, that means the long tail of risk is never systematically measured, even though mortality, rehospitalisation, and disability remain in play long after the first discharge.
A single injury can disturb multiple organ systems at once. The commentary points to trauma-induced hypopituitarism, autonomic dysregulation, accelerated ageing, and cognitive-behavioural impairment as risks that do not fit neatly into standard post-injury pathways. Existing cardiovascular, endocrine, and psychiatric services often screen for their own disease categories, but they do not reliably capture the neurotrauma-specific pattern that emerges after TBI or SCI.
In practice, that gap matters at the bedside. A patient may present months later with mood symptoms, blood pressure instability, fatigue, pain, sleep disruption, or cognitive decline, yet those problems can be interpreted in isolation rather than as part of a chronic post-traumatic syndrome. The result is delayed recognition, missed surveillance, and preventable deterioration.
A chronic-care model built around risk, not one-time discharge
Marini and colleagues propose a risk-stratified pathway of care navigation rather than a one-size-fits-all follow-up plan. Their model pairs multisystem screening with telehealth and aims to connect neurotrauma care with adjacent services already managing related complications, including stroke, cardiometabolic disease, memory disorders, psychiatric illness, pain, and epilepsy.
The logic is clinically coherent. TBI and SCI do not remain confined to a single organ system after injury, so follow-up should not remain confined to a single specialty either. A structured network would allow patients with higher risk profiles to move through targeted surveillance, while lower-risk patients still remain visible to clinicians who can detect delayed endocrine, autonomic, psychiatric, or neurologic complications before they harden into permanent disability.
Telehealth has a practical role in that design. Neurotrauma survivors often face mobility limitations, transportation barriers, cognitive fatigue, and fragmented specialty access. Remote follow-up can reduce the chance that long-term symptoms disappear between appointments, especially when care must extend across years rather than weeks.
The proposed endpoints are measurable and public-health relevant
The commentary does not stop at philosophy. It explicitly ties the proposed care pathway to measurable outcomes: reductions in 5-year mortality, avoidable rehospitalisation, and long-term disability. Those outcomes are the right ones for a condition whose burden is delayed, cumulative, and multisystemic.
This is where the argument becomes more than a classification debate. If TBI and SCI are treated as chronic risk conditions, then registries, workforce planning, and financing structures can be built to track patients over time rather than releasing them into a system that assumes the acute phase was the entire disease. Without that shift, the most consequential complications remain invisible until they become irreversible.
A one-time trauma admission does not erase the years of downstream risk.
Registry, workforce, and financing reforms are part of the clinical intervention
The authors also call for financing, workforce, and registry reforms needed to make long-term care real. This is not administrative garnish. Chronic disease management requires systems that can identify who needs follow-up, who is missing from follow-up, which complications are emerging, and which service lines are absorbing the burden.
Registry infrastructure is especially important in neurotrauma because the clinical picture evolves. Early cognitive impairment may later intersect with psychiatric symptoms, endocrine dysfunction, or autonomic instability. Without a registry or longitudinal tracking mechanism, each problem can be documented separately and none can be assembled into a coherent disease course.
Workforce planning is just as essential. Neurotrauma care spans neurology, rehabilitation, endocrinology, cardiometabolic medicine, psychiatry, pain care, epilepsy services, and primary care. The proposed model assumes that no single clinic can manage the full burden alone, and that the safe path is coordinated longitudinal care rather than episodic referral.
Reclassification could change who gets monitored and when
Reframing TBI and SCI as chronic multisystem disorders would change which patients are followed, how long they are followed, and what gets screened along the way. It would also force health systems to think about risk before complications become entrenched. In that sense, the proposal is both biological and operational: the injury alters physiology, and the care model must alter accordingly.
The commentary makes a strong case that neurotrauma belongs in the same long-term care conversation as other chronic neurologic diseases, even though the initiating event is abrupt. The acute injury is only the beginning of the clinical timeline. What follows can include endocrine failure, cardiovascular instability, psychiatric illness, pain, epilepsy, and cognitive-behavioural decline that accumulate across years.
The remaining challenge is implementation. Health systems will need to prove that integrated surveillance, telehealth, and registry-supported coordination can actually reduce mortality, rehospitalisation, and disability at scale. Until then, the argument for chronic-care reclassification is compelling on biological grounds, but the operational test still lies ahead.